unknown
Stage
1
Investors
About
21st Solutions develops AmyletiX, a technology that improves delivery and bioavailability of hydrophobic ingredients for pharmaceutical, nutraceutical, cosmetic, food & beverage, and pet care applications.
Explore 21st.BIO's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.